NASDAQ:SIGA - Nasdaq - US8269171067 - Common Stock - Currency: USD
5.84
-0.29 (-4.73%)
The current stock price of SIGA is 5.84 USD. In the past month the price decreased by -9.88%. In the past year, price decreased by -21.72%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 51.98 | 678.00B | ||
JNJ | JOHNSON & JOHNSON | 15.19 | 367.19B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 19.48 | 302.61B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.54 | 222.20B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.87B | ||
MRK | MERCK & CO. INC. | 9.99 | 195.88B | ||
PFE | PFIZER INC | 7.18 | 130.67B | ||
SNY | SANOFI-ADR | 13.67 | 128.55B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.41 | 95.71B | ||
GSK | GSK PLC-SPON ADR | 7.06 | 78.75B | ||
ZTS | ZOETIS INC | 26.91 | 72.25B | ||
HLN | HALEON PLC-ADR | 22.57 | 49.87B |
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The company is headquartered in New York City, New York and currently employs 46 full-time employees. The firm is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
SIGA TECHNOLOGIES INC
31 East 62Nd Street
New York City NEW YORK 10065 US
CEO: Phillip L. Gomez
Employees: 46
Phone: 12126729100
The current stock price of SIGA is 5.84 USD. The price decreased by -4.73% in the last trading session.
The exchange symbol of SIGA TECHNOLOGIES INC is SIGA and it is listed on the Nasdaq exchange.
SIGA stock is listed on the Nasdaq exchange.
SIGA TECHNOLOGIES INC (SIGA) has a market capitalization of 417.21M USD. This makes SIGA a Small Cap stock.
SIGA TECHNOLOGIES INC (SIGA) currently has 46 employees.
SIGA TECHNOLOGIES INC (SIGA) has a support level at 5.47 and a resistance level at 6.09. Check the full technical report for a detailed analysis of SIGA support and resistance levels.
The Revenue of SIGA TECHNOLOGIES INC (SIGA) is expected to decline by -24.12% in the next year. Check the estimates tab for more information on the SIGA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SIGA TECHNOLOGIES INC (SIGA) has a dividend yield of 10.02%. The yearly dividend amount is currently 0.6. Check the full fundamental report for a detailed analysis of SIGA dividend history, reliability and sustainability.
SIGA TECHNOLOGIES INC (SIGA) will report earnings on 2025-07-30.
The PE ratio for SIGA TECHNOLOGIES INC (SIGA) is 8.72. This is based on the reported non-GAAP earnings per share of 0.67 and the current share price of 5.84 USD. Check the full fundamental report for a full analysis of the valuation metrics for SIGA.
The outstanding short interest for SIGA TECHNOLOGIES INC (SIGA) is 10.24% of its float. Check the ownership tab for more information on the SIGA short interest.
ChartMill assigns a technical rating of 2 / 10 to SIGA. When comparing the yearly performance of all stocks, SIGA is a bad performer in the overall market: 72.93% of all stocks are doing better.
ChartMill assigns a fundamental rating of 7 / 10 to SIGA. SIGA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months SIGA reported a non-GAAP Earnings per Share(EPS) of 0.67. The EPS decreased by -39.09% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 42.69% | ||
ROA | 24.23% | ||
ROE | 27.44% | ||
Debt/Equity | 0 |
For the next year, analysts expect an EPS growth of -17.9% and a revenue growth -24.12% for SIGA